Cyrus Harmon
2020
In 2020, Cyrus Harmon earned a total compensation of $4M as Chief Technology Officer and former Chief Executive Officer at Olema Pharmaceuticals, a 1,226% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,158 |
|---|---|
| Option Awards | $2,974,853 |
| Salary | $395,833 |
| Stock Awards | $344,046 |
| Total | $3,976,890 |
Harmon received $3M in option awards, accounting for 75% of the total pay in 2020.
Harmon also received $262.2K in non-equity incentive plan, $395.8K in salary and $344K in stock awards.
Rankings
In 2020, Cyrus Harmon's compensation ranked 2,866th out of 13,090 executives tracked by ExecPay. In other words, Harmon earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,866 out of 13,090 | 78th |
Division Manufacturing | 1,102 out of 5,621 | 80th |
Major group Chemicals And Allied Products | 407 out of 2,254 | 82nd |
Industry group Drugs | 351 out of 1,954 | 82nd |
Industry Pharmaceutical Preparations | 257 out of 1,459 | 82nd |
Source: SEC filing on April 27, 2021.
Harmon's colleagues
We found three more compensation records of executives who worked with Cyrus Harmon at Olema Pharmaceuticals in 2020.